TC BioPharm (Holdings) plc ADR (TCBP) Shares Up Despite Recent Market Volatility

TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP)’s stock price has increased by 71.54 compared to its previous closing price of 1.30. However, the company has seen a 55.94% increase in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-11-28 that The FDA clears TC BioPharm’s (TCBP) investigational new drug application seeking approval to begin a clinical study on its pipeline candidate, TCB008, for treating acute myeloid leukemia. Stock declines.

Is It Worth Investing in TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP) Right Now?

Additionally, the 36-month beta value for TCBP is 0.29. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The average trading volume of TCBP on April 04, 2024 was 3.29M shares.

TCBP’s Market Performance

TCBP stock saw an increase of 55.94% in the past week, with a monthly gain of 76.98% and a quarterly increase of -3.46%. The volatility ratio for the week is 10.40%, and the volatility levels for the last 30 days are 19.67% for TC BioPharm (Holdings) plc ADR (TCBP). The simple moving average for the last 20 days is 52.95% for TCBP stock, with a simple moving average of -65.98% for the last 200 days.

TCBP Trading at 68.02% from the 50-Day Moving Average

After a stumble in the market that brought TCBP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.93% of loss for the given period.

Volatility was left at 19.67%, however, over the last 30 days, the volatility rate increased by 10.40%, as shares surge +128.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +12.68% upper at present.

During the last 5 trading sessions, TCBP rose by +67.83%, which changed the moving average for the period of 200-days by -80.33% in comparison to the 20-day moving average, which settled at $1.5255. In addition, TC BioPharm (Holdings) plc ADR saw -29.65% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for TCBP

Equity return is now at value -94.90, with -13.34 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 1.09.


In conclusion, TC BioPharm (Holdings) plc ADR (TCBP) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts